Design and Evaluation of Sorafenib Tosylate Nanoparticles Including Assessment of IC50 Values using PC Cell Lines
P. B. Sailaja & B. Jeevana Jyothi · Journal of Pharmaceutical Research International · 2022
Introduction: Sorafenib tosylate is an anticancer drug used for treatment of pancreatic cancer. In the present research work, Sorafenib tosylate is converted to nanoparticles with an aim to assess its anticancer activity with reduced concentration expecting less side effects of t...
Open access
Research Article
10.9734/jpri/2022/v34i36B36190